BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2707762)

  • 1. Langerhans cells in human lung tumours: an immunohistological study.
    Fox SB; Jones M; Dunnill MS; Gatter KC; Mason DY
    Histopathology; 1989 Mar; 14(3):269-75. PubMed ID: 2707762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extremely high Langerhans cell infiltration contributes to the favourable prognosis of HPV-infected squamous cell carcinoma and adenocarcinoma of the lung.
    Miyagi J; Kinjo T; Tsuhako K; Higa M; Iwamasa T; Kamada Y; Hirayasu T
    Histopathology; 2001 Apr; 38(4):355-67. PubMed ID: 11318901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67 immunostaining and survival in operable lung cancer.
    Tungekar MF; Gatter KC; Dunnill MS; Mason DY
    Histopathology; 1991 Dec; 19(6):545-50. PubMed ID: 1664810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cytokines in distribution and differentiation of dendritic cell/Langerhans' cell lineage in human primary carcinomas of the lung.
    Colasante A; Castrilli G; Aiello FB; Brunetti M; Musiani P
    Hum Pathol; 1995 Aug; 26(8):866-72. PubMed ID: 7635448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Langerhans cells and lymphocyte subsets in human gastrointestinal carcinomas. An immunohistological study on frozen sections.
    Papadimitriou CS; Datseris G; Costopoulos JS; Bai MK; Ioachim-Velogianni E; Katsouyannopoulos V
    Pathol Res Pract; 1992 Dec; 188(8):989-94. PubMed ID: 1300611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approach to assessing lung tumours in man.
    Gatter KC; Dunnill MS; Gerdes J; Stein H; Mason DY
    J Clin Pathol; 1986 Jun; 39(6):590-3. PubMed ID: 3013945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of peripheral lung tumours related to size of the primary.
    Treasure T; Belcher JR
    Thorax; 1981 Jan; 36(1):5-8. PubMed ID: 7292381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Langerhans' cells and T cells in human skin tumours: an immunohistological study.
    Gatter KC; Morris HB; Roach B; Mortimer P; Fleming KA; Mason DY
    Histopathology; 1984 Mar; 8(2):229-44. PubMed ID: 6233213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lung tumours: does intermediate filament co-expression correlate with other morphological or immunocytochemical features?
    Gatter KC; Dunnill MS; Heryet A; Mason DY
    Histopathology; 1987 Jul; 11(7):705-14. PubMed ID: 3040564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of metallothionein expression in non-small cell lung carcinomas.
    Dziegiel P; Jeleń M; Muszczyńska B; Maciejczyk A; Szulc A; Podhorska-Okołów M; Cegielski M; Zabel M
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():43-5. PubMed ID: 15638370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cells in Langerhans cell histiocytosis and peripheral adenocarcinomas of the lung.
    Colasante A; Poletti V; Rosini S; Ferracini R; Musiani P
    Am Rev Respir Dis; 1993 Sep; 148(3):752-9. PubMed ID: 7690210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of p53 immunostaining to survival in carcinoma of the lung.
    McLaren R; Kuzu I; Dunnill M; Harris A; Lane D; Gatter KC
    Br J Cancer; 1992 Oct; 66(4):735-8. PubMed ID: 1329907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical study of lung carcinomas using a monoclonal antibody which specifically reacts to basal cells.
    Maeda K; Sueishi K
    Mod Pathol; 1990 Jan; 3(1):43-8. PubMed ID: 2155419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical study of RAS oncoprotein in cytologic specimens of primary lung tumours.
    Koutselini H; Kappatou G; Yiagnisis M; Field JK; Spandidos DA
    Anticancer Res; 1990; 10(3):597-603. PubMed ID: 2164347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinicopathologic study of the resected cases of adenosquamous carcinoma of the lung.
    Kamiyoshihara M; Hirai T; Kawashima O; Ishikawa S; Morishita Y; Maeshima A
    Oncol Rep; 1998; 5(4):861-5. PubMed ID: 9625833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic characteristics of adenosquamous carcinoma of the lung.
    Takamori S; Noguchi M; Morinaga S; Goya T; Tsugane S; Kakegawa T; Shimosato Y
    Cancer; 1991 Feb; 67(3):649-54. PubMed ID: 1985759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of proliferation rates assessed using "multiblock" and conventional tissue blocks of lung carcinoma.
    Brown DC; Gatter KC
    J Clin Pathol; 1992 Jul; 45(7):579-82. PubMed ID: 1355493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The postoperative survival in pulmonary carcinomas depending on the histological type and stage].
    Campobasso O; Andrion A; Mancuso M; De Simone M; Ribotta M
    Ann Osp Maria Vittoria Torino; 1989-1990; 31():9-24. PubMed ID: 2562416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between squamous cell carcinoma and adenocarcinoma of the lung: are adenocarcinoma and squamous cell carcinoma prognostically equal?
    Kawase A; Yoshida J; Ishii G; Nakao M; Aokage K; Hishida T; Nishimura M; Nagai K
    Jpn J Clin Oncol; 2012 Mar; 42(3):189-95. PubMed ID: 22210923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
    Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
    Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.